Journal: Heliyon
Article Title: Enhancing docetaxel efficacy and reducing toxicity using biodegradable periodic mesoporous organosilica nanoparticles
doi: 10.1016/j.heliyon.2024.e40131
Figure Lengend Snippet: The viability (%) of (A) Hs68 fibroblast cells; (B) VcaP prostate cancer cells; (C) A549 human lung adenocarcinoma cells and (D) MCF-7 breast cancer cells treated with BPMO, MSN, DTX, BPMO@DTX, and MSN@DTX was evaluated using the MTT assay. N = 3. ∗, ∗∗, and ∗∗∗ indicate p < 0.05, <0.01, and <0.001, respectively (Student t-test).
Article Snippet: These analyses used the normal human fibroblast cell line Hs68 (source ATCC, supplier Sigma-Aldrich), the prostate cancer cell line VcAP (source ATCC, supplier Sigma-Aldrich), the human lung adenocarcinoma cell line A549 (source ATCC, supplier Sigma-Aldrich) and the breast cancer cell line MCF-7 (source ATCC, supplier Sigma-Aldrich).
Techniques: MTT Assay